Research from MIA was once again in the spotlight as findings were shared at the virtual ASCO21. 

In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.

Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.

As leaders in the field of melanoma, clinicians and researchers from MIA shared their knowledge at the virtual 10^th World Congress of Melanoma. 

The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.

Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.

There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form. 

The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.

Melanoma research saved Bert's life at 101 and now he wants to give back. 

Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.

Aussies urged to leave their footprint on melanoma as efforts step up to save lives from the disease.

Olivia is using her Ninja star power to shine a spotlight on melanoma prevention - in memory of her dad. 

Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.

New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.

Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate. 

A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.

All Australians are urged to join the fight against melanoma this summer. 

The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research. 

A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.

The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.

The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.

Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.

Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.

Join in the fun of the virtual event, and together we can run over melanoma!

Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.

Participate in our online survey and help us understand the support needs of melanoma patients and carers.

Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.

MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.

More than 120 MIA clinicians, researchers and staff came together online to share research highlights.

For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.

As of Monday 27^th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask. 

In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.    

Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.

Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for  distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies. 

“I had a complete response within about six months. All of my tumours disappeared."

‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'